Clinical utility of PDX cohorts to reveal biomarkers of intrinsic resistance and clonal architecture changes underlying acquired resistance to cetuximab in HNSCC
Yanli Yao(Shanghai Ninth People's Hospital), Shuyang Sun(Shanghai Jiao Tong University)
Cited by 37
Related Papers
Analysis of Mucosal Melanoma Whole-Genome Landscapes Reveals Clinically Relevant Genomic Aberrations
|Clinical Cancer Research|2019|128